EXACT Sciences, headquartered in Madison, Wisconsin, focuses on cancer screening and diagnostics, employing 6,500 people. Its key products include the Cologuard test for colorectal cancer and Oncotype DX tests for breast cancer.
EXAS filed a patent for "compositions and methods for characterizing zdhhc1 dna" on Mon, July 17, 2023. The patent was officially published on Thu, January 23, 2025.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
